Journal of Clinical & Experimental Pharmacology

Kim Lawson

Kim Lawson
Department of Biosciences and Chemistry, Biomolecular Sciences Research Centre
Sheffield Hallam University, Faculty of Health and Wellbeing, United Kingdom

Biography

Dr. Kim Lawson received his PhD in pharmacology from Sunderland University (UK) in 1986. He is a pharmacologist with an international reputation in Drug Discovery Research, gained in academia and multinational pharmaceutical industries (France: Rhone-Poulenc, Recherche Syntex France; Belgium: Sanofi-Labaz; UK: Reckitt & Colman, British Biotech) and is now working at Sheffield Hallam University. His research interests and expertise are focused towards i) the identification of novel targets for the development of drugs for the treatment of fibromyalgia & ii) modulation of potassium channels as a therapeutic approach. Kim is regularly invited as a consultant to the pharmaceutical and healthcare industries & affiliated organizations, to talk at public events & scientific conferences, to write 'expert opinion' articles for scientific and clinical journals and to contribute to CME/CPD activities. He is the chair of the Medical Advisory Board to Fibromyalgia Action UK, in addition to being a Patron to Folly Pogs Fibromyalgia Research UK . Kim regularly publishes in, and is a member on the Editorial Boards of, international scientific and medical journals.

Research Interest

Dr. Kim Lawson has research interests and expertise focused towards the identification of novel targets for the development of drugs for the treatment of fibromyalgia and modulation of potassium channels as a therapeutic approach.